Hopes fading for stem cell cure for Parkinson’s
A major miracle needed
Parkinson’s
disease has always been one of the main candidates for stem cell
therapies. But a report in Sharon Begley’s Lab
Report blog at Newsweek
suggests that scientists’ early hopes are turning to pessimism.
Neurologist Jeffrey Kordower, of Chicago’s Rush Presbyterian
Medical Center, told a conference at Rockefeller University earlier
this month that it will be very difficult. “I’ve blogged before
on the growing realization that using stem cells, or cells derived
from stem cells, to repair neurological diseases is going to be
really, really hard” Begley reports. “But I’d never heard
someone of Kordower’s stature put it quite so starkly: ‘In my
opinion it will take a major miracle for stem cells to make a
difference in Parkinson’s disease.’” ~ Newsweek,
Oct 15
- How long can you put off seeing the doctor because of lockdowns? - December 3, 2021
- House of Lords debates assisted suicide—again - October 28, 2021
- Spanish government tries to restrict conscientious objection - October 28, 2021
More Stories
Mortality rates for American kids are rising for the first time in 50 years
US President Joe Biden is so concerned about the future of American children that he inserted a mandate for affordable...
Will Pope Francis be composted?
Will Pope Francis be composted instead of buried in St Peter’s Basilica in Rome with his predecessors? It’s unlikely. But...
The virtues and the vices of the outrageous
A Norwegian bioethicist, Anna Smajdor, recently set out a case for “Whole Body Gestational Donation” – using the wombs of...
More than 200 people have been treated with experimental CRISPR therapies
Scientists believe that CRISPR gene editing technologies will transform medicine. But how many people have been treated so far? According...
Asia-Pacific IVF market could reach US$46 billion by 2031
According to a market survey by Allied Market Research, IVF is booming in the Asia-Pacific region. The market size was...
Third global summit on human genome editing: Moving on after the He experiment
The much anticipated Third International Summit on Human Genome Editing was held in London earlier this month to explore the...